Compounds > sorafenib
Page last updated: 2024-09-05

sorafenib and Cancer, Second Primary

sorafenib has been researched along with Cancer, Second Primary in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (18.18)29.6817
2010's8 (72.73)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
Cao, D; Chi, Z; Cui, C; Guo, J; Kong, Y; Li, J; Li, S; Liu, Y; Mo, J; Sheng, X; Si, L; Wu, X; Xu, H; Yan, X; Zhou, L1
Cheng, SB; Huang, CC; Jan, YG; Lin, HC; Lin, YL; P'eng, FK; Shen, CH; Teng, CJ; Wu, CC; Yang, YS1
Fukuda, H; Iizuka, J; Ishihara, H; Kobayashi, H; Kondo, T; Omae, K; Takagi, T; Tanabe, K; Yoshida, K1
Fan, HK; Fan, J; Gao, Q; Ren, ZG; Xie, DY1
El Tal, AK; Ganger, LK; Mehregan, DA; Remichofsky, CJ1
Artaza Varasa, T; de la Cruz Pérez, G; Gómez Rodríguez, R; González de Frutos, C; Muñoz López, D; Romero Gutiérrez, M; Ruano Díaz, L; Sánchez Ruano, JJ1
Ando, Y; Bonichon, F; Brose, MS; Chung, J; Fassnacht, M; Fugazzola, L; Gao, M; Hadjieva, T; Hasegawa, Y; Kappeler, C; Meinhardt, G; Park, DJ; Schlumberger, M; Shi, Y; Shong, YK; Smit, JW; Worden, F1
Haley, H; Hamza, S; Skelton, HG; Smith, KJ1
Adnot-Desanlis, L; Bernard, P; Reguiaï, Z1
Ciampi Dopazo, JJ; de Artaza Varasa, T; de la Cruz Perez, G; Gómez Moreno, AZ; Gómez Rodríguez, R; González de Frutos, C; Lanciego Pérez, C; Romero Gutiérrez, M1
Bargetzi, M; Puric, E; Schönenberger, A; Sendi, P1

Reviews

1 review(s) available for sorafenib and Cancer, Second Primary

ArticleYear
Identifying Clonal Origin of Multifocal Hepatocellular Carcinoma and Its Clinical Implications.
    Clinical and translational gastroenterology, 2019, Volume: 10, Issue:2

    Topics: Biomarkers, Tumor; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Chromosome Aberrations; Clone Cells; Diagnosis, Differential; Hepatectomy; Hepatitis B virus; High-Throughput Nucleotide Sequencing; Humans; Liver; Liver Neoplasms; Mutation; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Patient Selection; Precision Medicine; Sorafenib; Treatment Outcome; Tumor Suppressor Protein p53

2019

Trials

1 trial(s) available for sorafenib and Cancer, Second Primary

ArticleYear
Safety and tolerability of sorafenib in patients with radioiodine-refractory thyroid cancer.
    Endocrine-related cancer, 2015, Volume: 22, Issue:6

    Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Aged; Antineoplastic Agents; Carcinoma, Papillary; Diarrhea; Disease-Free Survival; Drug Eruptions; Drug Resistance, Neoplasm; Dyspnea; Fatigue; Female; Humans; Hypertension; Hypocalcemia; Incidence; Iodine Radioisotopes; Male; Middle Aged; Neoplasms, Second Primary; Niacinamide; Phenylurea Compounds; Prevalence; Protein Kinase Inhibitors; Radiopharmaceuticals; Sorafenib; Thyroid Neoplasms; Weight Loss

2015

Other Studies

9 other study(ies) available for sorafenib and Cancer, Second Primary

ArticleYear
Clinicopathological characteristics and prognosis of metastatic collecting duct carcinoma.
    Urologic oncology, 2022, Volume: 40, Issue:8

    Topics: Axitinib; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Neoplasms, Second Primary; Prognosis; Retrospective Studies; Sorafenib

2022
Liver resection for hepatocellular carcinoma in patients with hematological malignancies.
    World journal of surgical oncology, 2017, Nov-02, Volume: 15, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Biomarkers; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Disease-Free Survival; Female; Hematologic Neoplasms; Hepacivirus; Hepatectomy; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Niacinamide; Patient Selection; Phenylurea Compounds; Postoperative Complications; Prognosis; Retrospective Studies; Serologic Tests; Sorafenib; Survival Rate; Young Adult

2017
Evaluation of renal function change during first-line tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma.
    Japanese journal of clinical oncology, 2017, Dec-01, Volume: 47, Issue:12

    Topics: Aged; Carcinoma, Renal Cell; Disease-Free Survival; Female; Glomerular Filtration Rate; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Neoplasms, Second Primary; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyrroles; Sorafenib; Sunitinib

2017
Multiple squamous cell carcinomas following treatment with sorafenib for renal cell carcinoma.
    International journal of dermatology, 2013, Volume: 52, Issue:12

    Topics: Aged; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Humans; Kidney Neoplasms; Male; Neoplasms, Second Primary; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Skin Neoplasms; Sorafenib

2013
[Percutaneous ablation of hepatocellular carcinoma in older patients in clinical practice].
    Gastroenterologia y hepatologia, 2015, Volume: 38, Issue:2

    Topics: Aged; Aged, 80 and over; Alcoholism; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Diabetes Complications; Ethanol; Female; Humans; Kaplan-Meier Estimate; Liver Cirrhosis; Liver Neoplasms; Male; Neoplasms, Second Primary; Niacinamide; Phenylurea Compounds; Prospective Studies; Remission Induction; Sorafenib

2015
Eruptive keratoacanthoma-type squamous cell carcinomas in patients taking sorafenib for the treatment of solid tumors.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2009, Volume: 35, Issue:11

    Topics: Adult; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Squamous Cell; Female; Humans; Keratoacanthoma; Male; Middle Aged; Neoplasms, Second Primary; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Skin Neoplasms; Sorafenib

2009
[Squamous cell carcinoma in a patient receiving sorafenib].
    Annales de dermatologie et de venereologie, 2011, Volume: 138, Issue:2

    Topics: Antineoplastic Agents; Benzenesulfonates; Biopsy; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Cooperative Behavior; Follow-Up Studies; Humans; Interdisciplinary Communication; Kidney Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Skin; Skin Neoplasms; Sorafenib; Vascular Endothelial Growth Factor A

2011
[Clinical characteristics, staging and treatment of patients with hepatocellular carcinoma in clinical practice. Prospective study of 136 patients].
    Gastroenterologia y hepatologia, 2011, Volume: 34, Issue:8

    Topics: Aged; Alcoholism; Benzenesulfonates; Carcinoma, Hepatocellular; Comorbidity; Diabetes Mellitus; Early Detection of Cancer; Ethanol; Female; Hepatitis, Viral, Human; HIV Infections; Humans; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasms, Second Primary; Niacinamide; Phenylurea Compounds; Prospective Studies; Pyridines; Sclerotherapy; Sorafenib; Spain

2011
[Chronic lymphocytic leukemia and loss of strength in the right arm--not a typical combination].
    Praxis, 2007, May-02, Volume: 96, Issue:18

    Topics: Administration, Oral; Aged; Antineoplastic Agents; Arm; Benzenesulfonates; Bone Neoplasms; Carcinoma, Renal Cell; Clinical Trials, Phase III as Topic; Disease Progression; Humans; Hypesthesia; Indoles; Kidney Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Male; Muscle Weakness; Neoplasms, Second Primary; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Radiography, Abdominal; Radiography, Thoracic; Risk; Risk Factors; Sex Factors; Sorafenib; Splenic Neoplasms; Sunitinib; Time Factors; Tomography, X-Ray Computed

2007